Abstract
A substantial body of research suggests that subclinical symptoms characterize the longitudinal course of major depression and have important pathophysiological and treatment implications. Specific treatment of residual symptoms may in fact improve long-term outcome, by acting on those residual symptoms that progress to become prodromes of relapse. The assessment of psychological well-being is also important, since its absence may create conditions of vulnerability to possible adversities. The route of recovery, thus, lies not exclusively in alleviating the negative, but in engendering the positive.
Similar content being viewed by others
References
Agosti V, Stewart JW, Quitkin FM, Ocepek-Welikson K (1993) How symptomatic do depressed patients remain after benefiting from medication treatment? Comp Psychiatry 34:182–186
Angst J, Kupfer DJ, Rosenbaum JF (1996) Recovery from depression: risk or reality? Acta Psychiat Scandinav 93:413–419
Bauwens F, Tray A, Pardoen D, Vander Eist M, Mendlewicz J (1991) Social adjustment of remitted bipolar and unipolar out-patients. Br J Psychiatry 159: 239–244
Bech P (1990) Measurement of psychological distress and well-being. Psychother Psychosom 54: 77–89
Benazzi F (2001) Prevalence and clinical correlates of residual depressive symptoms in bipolar II disorder. Psychother Psychosom 70: 232–238
Black KJ, Sheline YI (1997) Personality disorder scores improve with effective pharmacotherapy of depression. J Affect Disord 43:11–18
Bothwell R, Scott J (1997) The influence of cognitive variables on recovery in depressed inpatients. J Affect Disord 43:207–212
Brown GW, Bifulco A, Andrews B (1990) Self-esteem and depression. Soc Psychiatry Psychiat Epidemiol 25:244–249
Cadoret RJ, Widmer RB, Troughton EP (1980) Somatic complaints. Harbinger of depression in primary care. J Affect Disord 2:61–70
Casper RC, Katz MM, Bowden CL, Davis JM, Hoslow SH, Hanin I (1994) The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine. J Affect Disord 31:151–164
Chien AJ, Dunner DL (1996) The Tridimensional Personality Questionnaire in depression: state versus trait issues. J Psychiat Res 30: 21–27
Clayton PJ, Ernst C, Angst J (1994) Premorbid personality traits of men who develop unipolar or bipolar disorder. Eur Arch Psych Clin Neu-rosci 243: 340–346
Cornwall PL, Scott J (1997) Partial remission in depressive disorders. Acta Psychiat Scandinav 95:265–271
Coryell W, Scheftner W, Keller MB, Endicott J, Maser J, Klerman GL (1993) The enduring psychosocial consequences of mania and depression. Am J Psychiatry 150: 720–727
Detre TP, Jarecki H (1971) Modern Psychiatric Treatment. Lippincott: Philadelphia
Dryman A, Eaton WW (1991) Affective symptoms associated with the onset of major depression in the community. Acta Psychiat Scandinav 84:1–5
Eaves G, Rush AJ (1984) Cognitive patterns in symptomatic and remitted unipolar major depression. J Abn Psychol 93:31–40
Enns MW, Cox BJ (1997) Personality dimensions and depression. Can J Psychiatry 42:274–284
Ernst C, Schmid G, Angst J (1992) The Zurich study. XVI Early antecedents of depression. Eur Arch Psych Clin Neurosci 242: 142–151
Faravelli C, Ambonetti A, Pallanti S, Pazzagli A (1986) Depressive relapses and incomplete recovery from index episode. Am J Psychiatry 143:888–891
Fava GA (1999) Subclinical symptoms in mood disorders. Psychol Med 29:47–61
Fava GA (2001) Clinical psychology: a psychosocial antidote to biological reductivism in psychiatry? Epidemiol Psychiat Soc 10:150–152
Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, Wise TN (1995) Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 65: 1–8
Fava GA, Mangelli L (1999) Subclinical symptoms of panic disorder. Psychother Psychosom 68:281–289
Fava GA, Mangelli L, Ruini C (2001) Assessment of psychological distress in the setting of medical disease. Psychother Psychosom 70: 171–175
Fava GA, Kellner R (1991) Prodromal symptoms in affective disorders. Am J Psychiatry 148:823–830
Fava GA, Grandi S, Canestrari R, Molnar G (1990) Prodromal symptoms in primary major depressive disorder. J Affect Disord 19: 149–152
Fava GA, Grandi S, Zielezny M, Canestrari, R, Morphy MA (1994) Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 151:1295–1299
Fava GA, Grandi S, Zielezny M, Rafanelli C, Canestrari R (1996) Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry 153: 945–947
Fava GA, Kellner R, Lisansky J, Park S, Perini Gl, Zielezny M (1986) Rating depression in normals and depressives. J Affect Disord 11: 29–33
Fava GA, Rafanelli C, Cazzaro M, Conti S, Grandi S (1998a) Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders. Psychol Med 28:475–480
Fava GA, Rafanelli C, Grandi S, Conti S, Belluardo P (1998b) Prevention of recurrent depression with cognitive behavioral therapy. Arch Gen Psychiatry 55: 816–820
Fava M, Bouffides E, Pava JA, McCarthy MK, Steingard RJ, Rosenbaum JF (1994) Personality disorder comorbidity with major depression and response to fluoxetine treatment. Psychother Psychosom 62: 160–167
Frank E, Kupfer DJ, Perel JM, Cornes C, Jarrett DB, Mallinger AG, Thase ME, McEachran AB, Grochocinsky VJ (1990) Three year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 47:1093–1099
Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM (1991) Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Arch Gen Psychiatry 48: 851–855
Georgotas A, McCue RE (1989) Relapse of depressed patients after effective continuation therapy. J Affect Disord 17:159–164
Goering PN, Lancee WJ, Freeman SJJ (1992) Marital support and recovery from depression. Br J Psychiatry 160:76–82
Grandi S, Fabbri S, Tossani E, Mangelli L, Branzi A, Magelli C (2001) Psychological evaluation after cardiac transplantation. Psychother Psychosom 70:176–183
Haskell DS, di Mascio A, Prusoff B (1975) Rapidity of symptom reduction in depressions treated with amitriptyline. J Nerv Ment Disease 160: 24–33
Hays P (1964) Modes of onset of psychotic depression. Br Med J ii: 779–784
Hopkinson G (1965) The prodromal phase of the depressive psychosis. Psychiat Neurol 149:1–6
Judd LL, Paulus MJ, Schettler PJ, Akiskal HS, Endicott J, Leon AC, Maser JD, Mueller T, Solomon DA, Keller MB (2000) Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 157:1501–1504
Judd LL, Akiskal HS, Paulus MP (1997) The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. J Affect Disord 45: 5–18
Katz MM, Koslow SH, Maas JW, Frazer A, Bowden CL, Casper R, Croughan J, Kocsis J, Redmond E (1987) The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med 17: 297–309
Keller MB, Lavori PW, Endicott J, Coryell W, Klerman GL (1983) Double depression: two year follow-up. Am J Psychiatry 140: 689–694
Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RMA, Shea T (1992) Time to recovery, chronicity, and levels of psy-chopathology in major depression. Arch Gen Psychiatry 49:809–816
Klosterkotter J, Martin H, Eckhard S, Schultze-Lutter F (2001) Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 58:158–164
Mahnert FA, Reicher H, Zalandek K, Zapotoczky HG (1997) Prodromal and residual symptoms in recurrent depression. Eur Neuropsy-chopharmac 7 (Suppl 2): S158-S159
Maj M, Veltro F, Pirozzi R, Lobrace S, Magliano L (1992) Pattern of recurrence of illness after recovery from an episode of major depression. Am J Psychiatry 149: 795–800
Mayer Gross Slater Roth (1969) Clinical Psychiatry. Bailliere and Tindall: London (third edition revised)
Mindham RH, Howland C, Shepherd M (1973) An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychol Med 3: 5–17
Murray LG, Blackburn IM (1974) Personality differences in patients with depressive illness and anxiety neurosis. Acta Psychiat Scandinav 50:183–191
Nierenberg AA, Keefe BR, Leslie VC, Alpert JE, Pava JA, Worthington JJ, Rosenbaum JJ, Fava M (1999) Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 60: 221–225
Nierenberg AA, McLean NE, Alpert JE, Worthington JJ, Rosenbaum JF, Fava M (1995) Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry 152:1500–1503
Nystrom S, Lindegard B (1975) Depression: predisposing factors. Acta Psychiat Scandinav 51: 77–87
Paykel ES (1985) The Clinical Interview for Depression. J Affect Disord 9: 85–96
Paykel ES, Prusoff BA, Tanner J (1976) Temporal stability of symptom patterns in depression. Br J Psychiatry 128:369–374
Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A (1995) Residual symptoms after partial remission: an important outcome in depression. Psychol Med 25:1171–1180
Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, Jenaway A, Cornwall PL, Hayhurst H, Abbott R, Pope M (1999) Prevention of relapse in residual depression by cognitive therapy. Arch Gen Psychiatry 56: 829–835
Paykel ES, Weissman MM (1973) Social adjustment and depression. Arch Gen Psychiatry 28: 659–664
Perris C, Eisemann M, von Knorring L, Perris H (1984) Personality-traits in former depressed patients and in healthy subjects without past history of depression. Psychopathology 17:178–186
Peselow ED, Sanfilipo MP, Fieve RR, Gubelkian G (1994) Personality traits during depression and after clinical recovery. Br J Psychiatry 164: 349–354
Piccinelli M, Wilkinson G (1994) Outcome of depression in psychiatric settings. Br J Psychiatry 164:297–304
Porcelli P, de Carne M, Fava GA (2000) Assessing somatization in functional gastrointestinal disorders. Psychother Psychosom 69: 189–204
Power MJ, Duggan CF, Lee AS, Murray RM (1995) Dysfunctional attitudes in depressed and recovered depressed patients and their first-degree relatives. Psychol Med 25: 87–93
Prien RF, Kupfer DJ (1986) Continuation drug therapy for major depressive episodes. Am J Psychiatry 143:18–23
Pyne JM, Patterson TL, Kaplan RM, Ho S, Gillin JG, Golshan S, Grant I (1997) Preliminary longitudinal assessment of quality of life in patients with major depression. Psychopharmacol Bull 33:23–29
Rafanelli C, Park S, Ruini C, Ottolini F, Cazzaro M, Fava GA (2000) Rating well-being and distress. Stress Med 16: 55–61
Raffi AR, Rondini M, Grandi S, Fava GA (2000) Life events and prodromal symptoms in bulimia nervosa. Psychol Med 30: 727–731
Ramana R, Paykel ES, Cooper Z, Hayhurst H, Saxty M, Surtees PG (1995) Remission and relapse in major depression. Psychol Med 25: 1161–1170
Rotschild R, Quitkin FM (1992) Review of the use of pattern analysis to differentiate true drug and placebo responses. Psychother Psychosom 58:170–177
Ryff CD, Singer BH (2000) Biopsychosocial challenges of the new mil-lenium. Psychother Psychosom 69:170–177
Sauer H, Richter P, Czernik A, Ludwig-Mayerhofer W, Schochlin C, Greil W, von Zerssen D (1997) Personality differences between patients with major depression and bipolar disorder. The impact of minor symptoms on self-ratings of personality. J Affect Disord 42: 169–177
Schnyder U, Buchi S, Sensky T, Klaghofer R (2000) Antonovsky’s sense of coherence. Psychother Psychosom 69:296–302
Schoenfeld WH, Verboncour CJ, Fifer SK, Lipschutz RC, Lübeck DP, Blesching DP (1997) The functioning and well-being of patients with unrecognized anxiety disorders and major depressive disorder. J Affect Disord 43:105–119
Shea MT, Elkin I, Imber S, Sotsky SM, Watkins JT, Collins JF, Pilkonis PA, Beckham E, Glass DR, Dolan RT, Parloff MB (1992) Course of depressive symptoms over follow-up. Arch Gen Psychiatry 49: 782–787
Shea MT, Leon AC, Mueller TI, Solomon DA, Warshaw MG, Keller MB (1996) Does major depression result in lasting personality change? Am J Psychiatry 153:1404–1410
Simons AD, Murphy GE, Levine JL, Wetzel RD (1986) Cognitive therapy and pharmacotherapy of depression. Arch Gen Psychiatry 43: 43–50
Stassen HH, Delini-Stula A, Angst J (1993) Time course of improvement under antidepressant treatment. Eur Neuropsychopharm 3: 127–135
Stewart AL, Sherbourne CD, Wells KB, Burnam MA, Rogers WH, Hayes RD, Ware JE (1993) Do depressed patients in different settings have different levels of well-being and functioning? J Consult Clinical Psychol 61: 849–857
Thase ME, Simons AD, McGeary J, Cabalane JF, Hughes C, Harden T, Friedman E (1992) Relapse after cognitive behavior therapy of depression. Am J Psychiatry 149:1046–1052
Thunedborg K, Black CH, Bech P (1995) Beyond the Hamilton depression scores in long-term treatment of manic-melancholic patients: prediction of recurrence of depression by quality of life measurements. Psychother Psychosom 64:130–140
van Praag HM (1992) About the centrality of mood lowering in mood disorders. Eur Neuropsychopharm 2: 393–404
Watkins JT, Leber WR, Imber SD, Collins JF, Elkin I, Pilkonis PA, Sotsky SM, Shea MT, Glass DR (1993) Temporal course of change of depression. J Consult Clin Psychol 61: 858–864
Weissman MM, Kasl SV, Klerman GL (1976) Follow-up of depressed women after maintenance treatment. Am J Psychiatry 133:757–760
Williams JMG, Healy D, Teasdale JD, White W, Paykel ES (1990) Dysfunctional attitudes and vulnerability to persistent depression. Psychol Med 20: 375–381
Winokur G (1976) Duration of illness prior to hospitalization (onset) in the affective disorders. Neuropsychobiology 2: 87–93
Young MA, Grabler P (1985) Rapidity of symptom onset in depression. Psychiat Res 16:309–315
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fava, G.A., Mangelli, L. Assessment of subclinical symptoms and psychological well-being in depression. Eur Arch Psychiatry Clin Nuerosci 251 (Suppl 2), 47–52 (2001). https://doi.org/10.1007/BF03035127
Issue Date:
DOI: https://doi.org/10.1007/BF03035127